Effectiveness evaluation of mood disorder treatment algorithms in Brazilian public healthcare patients

被引:3
|
作者
Lima, Ana F. [1 ]
Miguel, Sandro R. [1 ]
Cohen, Mirian [1 ]
Zimmermann, Jacques J. [1 ]
Shansis, Flavio M. [2 ]
Cruz, Luciane N. [1 ]
Ziegelmann, Patricia K. [1 ,3 ,4 ]
Polanczyk, Carisi A. [1 ,4 ]
Fleck, Marcelo P. [5 ]
机构
[1] HCPA, IATS, Rua Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, Brazil
[2] Hosp Psiquiatr Sao Pedro, Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Inst Matemat, Dept Estat, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Saude Cardiol & Ciencia, Porto Alegre, RS, Brazil
[5] Univ Fed Rio Grande do Sul, Fac Med, Dept Psiquiatria & Med Legal, Porto Alegre, RS, Brazil
关键词
Mood disorders; bipolar; mood disorders; unipolar; clinical drug studies; economic issues; epidemiology; ANXIETY TREATMENTS CANMAT; BIPOLAR DEPRESSION; INTERNATIONAL SOCIETY; ANTIDEPRESSANT USE; CANADIAN NETWORK; RELIABILITY; PREVALENCE; GUIDELINES; MANAGEMENT; VALIDITY;
D O I
10.1590/1516-4446-2016-2147
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To assess the effectiveness of three mood disorder treatment algorithms in a sample of patients seeking care in the Brazilian public healthcare system. Methods: A randomized pragmatic trial was conducted with an algorithm developed for treating episodes of major depressive disorder (MDD), bipolar depressive episodes and mixed episodes of bipolar disorder (BD). Results: The sample consisted of 259 subjects diagnosed with BD or MDD (DSM-IV-TR). After the onset of symptoms, the first treatment occurred similar to 6 years and the use of mood stabilizers began similar to 12 years. All proposed algorithms were effective, with response rates around 80%. The majority of the subjects took 20 weeks to obtain a therapeutic response. Conclusions: The algorithms were effective with the medications available through the Brazilian Unified Health System. Because therapeutic response was achieved in most subjects by 20 weeks, a follow-up period longer than 12 weeks may be required to confirm adequate response to treatment. Remission of symptoms is still the main desired outcome. Subjects who achieved remission recovered more rapidly and remained more stable over time.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 50 条
  • [21] Evaluation of Mood Disorder Questionnaire (MDQ) in Patients with Mood Disorders: A Multicenter Trial across China
    Yang, Hai-Chen
    Liu, Tie-Bang
    Rong, Han
    Bi, Jian-Qiang
    Ji, Er-Ni
    Peng, Hong-Jun
    Wang, Xiao-Ping
    Fang, Yi-Ru
    Yuan, Cheng-Mei
    Si, Tian-Mei
    Lu, Zheng
    Hu, Jian
    Chen, Zhi-Yu
    Huang, Yi
    Sun, Jing
    Li, Hui-Chun
    Hu, Chen
    Zhang, Jin-Bei
    Li, Ling-Jiang
    PLOS ONE, 2014, 9 (04):
  • [22] ECONOMIC EVALUATION OF TREATMENT SEQUENCES FOR THE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN THE ECUATORIAN PUBLIC HEALTHCARE SECTOR
    Rosado-Buzzo, A.
    Luna-Casas, G.
    Garcia-Molliendo, L.
    Albuja, M.
    VALUE IN HEALTH, 2015, 18 (03) : A162 - A162
  • [23] BUDGET IMPACT OF THE INCLUSION OF OXYCODONE IN THE BRAZILIAN PUBLIC HEALTHCARE SETTING FOR THE TREATMENT OF CANCER PAIN
    Souza, D. A.
    Aguiar, E. C.
    Miguel, A. K.
    Rosim, R. P.
    Ballalai Ferraz, A. F.
    VALUE IN HEALTH, 2017, 20 (09) : A891 - A892
  • [24] Determination of treatment participation and affecting factors of bipolar patients with mood disorder
    Bahar, Guven
    Savas, Haluk A.
    Unal, Ahmet
    Bahar, Aynur
    JOURNAL OF MOOD DISORDERS, 2015, 5 (03) : 95 - 103
  • [25] Characterisation of treatment resistant mood disorder patients in the United Arab Emirates
    Arnone, Danilo
    Stip, Emmanuel
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2025,
  • [26] ECONOMIC EVALUATION OF ISAVUCONAZOLE VERSUS VORICONAZOLE FOR THE TREATMENT OF PATIENTS WITH POSSIBLE INVASIVE ASPERGILLOSIS IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Araujo, G. L., V
    Murta Amaral, L.
    Penetti, R.
    VALUE IN HEALTH, 2022, 25 (12) : S71 - S71
  • [27] COST-EFFECTIVENESS OF NIVOLUMAB VERSUS DACARBAZINE IN FIRST-LINE TREATMENT OF ADVANCED MELANOMA FROM BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE
    Casagrande Oliveira, A. P.
    Hamza, S.
    Koloszuk, A.
    Marinheiro, P.
    Bernardino, G.
    VALUE IN HEALTH, 2020, 23 : S41 - S41
  • [28] The BREATH Study: The Brazilian Experimental Algorithms for the Treatment of bipolar disorders in the public Health system
    Shansls, F. M.
    Lima, A. F. B.
    Gimeno, L.
    Oilveira, A. L.
    Olderich, V.
    Barcellos, A.
    Magalhaes, L.
    Marostica, L.
    BIPOLAR DISORDERS, 2010, 12 : 50 - 50
  • [29] Effectiveness of psychodynamic treatment in patients with borderline personality disorder
    Martens W.H.J.
    Journal of Contemporary Psychotherapy, 2006, 36 (4) : 167 - 173
  • [30] Economic evaluation of antipsychotic drugs for schizophrenia treatment within the Brazilian Healthcare System
    Lindner, Leandro Mendonca
    Marasciulo, Antonio Carlos
    Farias, Mareni Rocha
    Motta Grohs, Geder Evandro
    REVISTA DE SAUDE PUBLICA, 2009, 43